
																
																	EMS in Viracept—The course of events in 2007 and 2008 from the non-clinical safety point of view
																
																
																
															Keywords: Viracept; Nelfinavir mesilate; Ethyl methanesulfonate; Regulatory interaction; Patient exposure risk